Robotic Assisted Right Colectomy With the DEXTER Robotic Surgery System
RACER
1 other identifier
observational
33
3 countries
4
Brief Summary
This study aims to confirm the perioperative and early postoperative safety and clinical performance (efficacy) of the Dexter Robotic System, in patients undergoing robotic-assisted right colectomy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Aug 2025
4 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 5, 2025
CompletedFirst Submitted
Initial submission to the registry
August 8, 2025
CompletedFirst Posted
Study publicly available on registry
August 14, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
September 1, 2026
April 13, 2026
April 1, 2026
1.1 years
August 8, 2025
April 10, 2026
Conditions
Outcome Measures
Primary Outcomes (2)
Primary safety outcome
Occurrence of Clavien-Dindo grades III-V adverse events
up to 30 days after surgery
Primary efficacy outcome
Successful completion of the Dexter-assisted procedure, i.e. free of any device related conversion to an open or fully laparoscopic surgical approach.
Intraoperative
Interventions
Robotic-assisted right colectomy with the DEXTER robotic surgery system
Eligibility Criteria
Adult patients undergoing a right colectomy for malignant or benign indication
You may qualify if:
- Aged \> 18 years
- Patient agrees to perform the 30-day follow-up assessment as per standard of care
You may not qualify if:
- History of radiotherapy on the target surgical area
- Patients with distant metastasis
- Any planned concomitant procedures
- History of major abdominal surgery
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Distalmotion SAlead
- Confiniscollaborator
Study Sites (4)
CH Châteauroux - Le Blanc
Châteauroux, 36000, France
Artemed Klinikum München Süd
Munich, 81379, Germany
Spitäler FMI AG
Interlaken, Switzerland
SRO AG Spital Langenthal
Langenthal, 4900, Switzerland
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 8, 2025
First Posted
August 14, 2025
Study Start
August 5, 2025
Primary Completion (Estimated)
September 1, 2026
Study Completion (Estimated)
September 1, 2026
Last Updated
April 13, 2026
Record last verified: 2026-04